Posted in I - Series E, Q - 3Q11, R - WEST, X - Friedreich's Ataxia, X - Mitochondrial, XX - CA
Edison Pharmaceuticals (Mountain View, CA) a clinical-stage small molecule company focused on mitochondrial disease Friedreich’s ataxia, closed a $4.1M Series E financing. Participants were not identified. Thanx for your patience as we catch-up.
to top of page...